Sharon Brangman's guest appearances

Sharon Brangman

GeriPal

OwlTail

Ramona Rhodes

Tim Farrell

Nancy Lundebjerg

The Covid epidemic laid bare two major structural issues.  First, Black and Latinx persons experienced much higher rates of mortality than other groups.  Second, as we discussed in  last week’s podcast, older adults, particularly those in nursing homes, were far more likely to die than younger individuals.  These are structural issues because the fundamental causes of these issues were not biological issues, they were social.  These worse outcomes were not due to differences in genes, they are due to structural racism and ageism.  In today’s podcast we talk about the intersection of racism and ageism.  We use the Covid pandemic and lack of diversity in trials for recently approved Alzheimer’s drugs  aducanumab and (to a lesser extent)  lecanemab as springboards for discussion.  Our guests Tim Farrell, Ramona Rhodes, and Nancy Lunderbjerg wrote an  article in JAGS on this issue, and Sharon Brangman wrote a separate  JAGS article on the need to achieve diversity in study populations. In a third piece, Ramona Rhodes wrote about efforts to improve diversity, equity, and inclusion at JAGS (in the journal itself, including content and editorial leadership).  The article was titled, “Change is coming” - which also gives you a hint as to today’s song request. One final note: at the start of today’s podcast we thank one of our generous donors, Meg Wallhagen, and ask her why she donated to GeriPal.  A prior  guest on GeriPal, Meg is a tireless advocate and researcher for hearing impairment issues affecting older adults.  She has a study that is open to recruitment for any adult - hearing impaired or not - please see the blurb below to learn more and participate. Enjoy! -@Alex Smith  From Meg Wallhagen: The Federal Drug Administration (FDA) now allows hearing aids to be sold Over-the-Counter (OTC-HAs) to adults with mild to moderate hearing loss. We – Meg Wallhagen from UCSF and Nick Reed from John Hopkins University - are interested to learn what people like you know about OTC-HAs and if you would consider buying them. The survey should only take about 10-20 minutes to complete. If you are willing to consider taking the survey, please click on the following link to learn more.   https://ucsf.co1.qualtrics.com/jfe/form/SV_9ZbReHYH72m82gK

The Covid epidemic laid bare two major structural issues.  First, Black and Latinx persons experienced much higher rates of mortality than other groups.  Second, as we discussed in <a href="https://geripal.org/improving-nursing-home-quality-jasmine-travers-alice-bonner-isaac-longobardi-and-mike-wasserman/" rel="nofollow" target="_blank"> last week’s podcast</a>, older adults, particularly those in nursing homes, were far more likely to die than younger individuals.  These are structural issues because the fundamental causes of these issues were not biological issues, they were social.  These worse outcomes were not due to differences in genes, they are due to structural racism and ageism.  In today’s podcast we talk about the intersection of racism and ageism.  We use the Covid pandemic and lack of diversity in trials for recently approved Alzheimer’s drugs <a href="https://geripal.org/aducanumab-aduhelm-for-the-treatment-of-alzheimers-a-podcast-with-aaron-kesselheim-and-jason-karlawish/" rel="nofollow" target="_blank"> aducanumab</a> and (to a lesser extent) <a href="https://geripal.org/is-it-time-for-geriatricians-to-get-on-board-with-lecanemab-jason-karlawish-and-ken-covinsky/" rel="nofollow" target="_blank"> lecanemab</a> as springboards for discussion.  Our guests Tim Farrell, Ramona Rhodes, and Nancy Lunderbjerg wrote an <a href="https://agsjournals.onlinelibrary.wiley.com/doi/10.1111/jgs.18105" rel="nofollow" target="_blank"> article in JAGS</a> on this issue, and Sharon Brangman wrote a separate <a href="https://agsjournals.onlinelibrary.wiley.com/doi/10.1111/jgs.18043" rel="nofollow" target="_blank"> JAGS article</a> on the need to achieve diversity in study populations. In a third piece, Ramona Rhodes wrote about efforts to improve diversity, equity, and inclusion at JAGS (in the journal itself, including content and editorial leadership).  The article was titled, “<a href="https://agsjournals.onlinelibrary.wiley.com/doi/10.1111/jgs.18015" rel="nofollow" target="_blank">Change is coming</a>” - which also gives you a hint as to today’s song request. One final note: at the start of today’s podcast we thank one of our generous <a href="https://givingtogether.ucsf.edu/fundraiser/3618721" rel="nofollow" target="_blank">donors</a>, Meg Wallhagen, and ask her why she <a href="https://givingtogether.ucsf.edu/fundraiser/3618721" rel="nofollow" target="_blank">donated</a> to GeriPal.  A prior <a href="https://geripal.org/hearing-loss-in-geriatrics-and-palliative-care-a-podcast-with-nick-reed-and-meg-wallhagen/" rel="nofollow" target="_blank"> guest on GeriPal</a>, Meg is a tireless advocate and researcher for hearing impairment issues affecting older adults.  She has a study that is open to recruitment for any adult - hearing impaired or not - please see the blurb below to learn more and participate. Enjoy! -@Alex Smith From Meg Wallhagen: The Federal Drug Administration (FDA) now allows hearing aids to be sold Over-the-Counter (OTC-HAs) to adults with mild to moderate hearing loss. We – Meg Wallhagen from UCSF and Nick Reed from John Hopkins University - are interested to learn what people like you know about OTC-HAs and if you would consider buying them. The survey should only take about 10-20 minutes to complete. If you are willing to consider taking the survey, please click on the following link to learn more.  <a href="https://ucsf.co1.qualtrics.com/jfe/form/SV_9ZbReHYH72m82gK" rel="nofollow" target="_blank"> https://ucsf.co1.qualtrics.com/jfe/form/SV_9ZbReHYH72m82gK</a>